Articles tagged with Human Immunodeficiency Virus
Routine HIV screening every three to five years is cost-effective in the US, according to Yale researchers. Frequent screening in high-risk populations could produce life expectancy gains at comparable costs to other chronic condition screenings.
A Family's Guide to Living with HIV is a comprehensive resource providing detailed information on the disease, its treatment, and its impact on daily life. The book also focuses on supporting psychological concerns, nutrition, education, and social activities for patients and their families.
A study by Mark A. Schuster found that nearly 40% of HIV-infected parents reported avoiding interactions with their children 'a little' due to fears of contagion, while 27.9% avoided certain interactions like hugging or kissing on the lips altogether.
A recent US study reveals that a significant portion of African Americans hold conspiracy theories about HIV/AIDS, which may frustrate efforts to combat the epidemic. Public health officials need to address these concerns and develop culturally sensitive strategies to reach at-risk populations.
A recent study found that HIV/AIDS conspiracy beliefs are associated with negative attitudes towards condoms and inconsistent condom use among African American men. The study suggests that addressing these beliefs is crucial in changing the disproportionately high rate of HIV and AIDS in this community.
A recent study found that male circumcision significantly reduces the risk of HIV transmission from women to men, with uncircumcised men facing a more than two-fold increased risk per sexual act. The study's results provide new insights into the rapid spread of HIV in settings where circumcision is not common.
Researchers identified adherence to medication regimen as key factor in developing HIV drug resistance. High adherence levels were associated with faster development of resistance, emphasizing the importance of strict medication adherence in maintaining treatment efficacy.
Researchers at Thomas Jefferson University have discovered that interleukin-7 (IL-7) can stimulate latent HIV viruses, making them vulnerable to drugs and the immune system. The new technique may lead to improved treatments for HIV infection and could be a step towards complete viral eradication.
The World Health Organization's "3 by 5" initiative aims to treat 3 million HIV-infected individuals in poor and middle-income countries by the end of 2005. Critics argue that this approach overlooks prevention strategies, is cash-strapped, and lacks country ownership.
The US government has awarded grants to support HIV/AIDS research and treatment in resource-limited countries, including Cambodia, Peru, Thailand, and Russia. The grants aim to develop clinical research centers and evaluate new treatments for co-infections with tuberculosis.
Researchers found that custom-designed facial implants provided excellent aesthetic postoperative outcomes for 22 patients with facial wasting syndrome. The use of high-resolution CT scans enabled precise modeling and sizing of implants, leading to stable and long-lasting results.
A study found that African-American patients treated by white doctors receive HIV medications nearly four months later than those treated by African-American doctors. Better communication and trust between patient and doctor of the same race may explain these differences.
The study demonstrates the value of clinical cutoffs in evaluating HIV drug resistance information. Clinical cutoffs based on a large outcomes database provide physicians with clinically relevant resistance information.
Researchers found evidence that HIV co-opts human enzyme DDX3 to transport its genetic material out of the cell nucleus. The discovery provides an attractive target for drug development and could lead to a new type of HIV drug that blocks viral replication without causing harm to human cells.
A Rutgers University nursing professor is developing digital video vignettes to reduce HIV sexual risk behavior. The project involves conducting focus groups with young women and men, analyzing their insights, and creating short videos on trust, pressure, and high-risk behaviors.
Researchers found that nevirapine significantly increases HDL cholesterol levels more than efavirenz, making it a preferable option for HIV-infected adults with increased cardiovascular risk. This study suggests that considering individual factors beyond cardiovascular risk can lead to more personalized treatment decisions.
Researchers have identified a potential target for preventing HIV transmission through vaginal membranes. A modified chemokine called PSC-RANTES was found to be effective in blocking SHIV transmission in rhesus macaques, offering hope for the development of a topical agent to prevent HIV infection in humans.
A new experimental drug called PSC-RANTES has shown promising results in preventing vaginal simian HIV transmission in monkeys. The study found that the highest dose of PSC-RANTES protected all five recipients from SHIV infection, suggesting a potential key target for strategies to prevent vaginal HIV transmission.
HBOCs increase tissue perfusion and oxygen delivery, offering a temporary solution for situations with massive hemorrhaging or blood shortages. They can effectively increase the usable blood supply in cardiac surgery, creating a 20% increase in supply.
Researchers found dopamine transporter injury in HIV dementia patients, suggesting a new direction for treatment. The study suggests that viral suppression may lead to recovery of deficits in the dopamine system.
The new guidelines cover prevention and early diagnosis of chronic conditions, such as diabetes and heart disease, and provide evidence-based primary care interventions for people living with HIV. The guidelines also focus on caring for women and children with HIV, making them a valuable resource for a wide range of healthcare providers.
Basic research on HIV is leading to new therapies that deny initial entry into cells. Fast-moving research on naturally occurring antiviral factors is opening the way for a new class of anti-HIV drugs.
Researchers mapped where three retroviruses integrate into human DNA, finding unique patterns for each. This discovery has implications for better-engineered gene therapies and new HIV drugs.
A study found prednisolone to be ineffective in treating HIV-associated pleural tuberculosis, increasing the risk of life-threatening cancer. The drug improved symptoms but showed no long-term benefits for patients without HIV infection.
A government policy providing free access to potent antiretroviral drugs has significantly reduced the HIV transmission rate in Taiwan, with an estimated decrease of 53%. The study, led by Chi-Tai Fang and Jung-Der Wang, used public health surveillance data to evaluate the impact of the policy on the country's HIV epidemic.
The Emory University Health Sciences Center, AABB, and Red Cross will work together to reduce HIV transmission in developing countries by improving blood supply systems, testing for HIV, and creating safe transfusion centers.
A groundbreaking study by Mount Sinai School of Medicine found that the combination of Pegasysα and Copegus significantly improved treatment response rates for patients co-infected with HCV and HIV. The study showed a sustained virological response rate of 40% among all patients, with even higher efficacy rates for those with genotypes...
A combination therapy of peginterferon alfa-2a and ribavirin achieved a 40% sustained virological response in co-infected patients, the highest ever reported. The treatment did not interfere with the effectiveness of HIV drugs, offering hope for previously untreated patients.
The Yale team will conduct research on implementing structural interventions among high-risk groups in southern India, aiming to reduce HIV transmission and promote healthier behavior. The project, funded by the Bill & Melinda Gates Foundation, aims to address social, economic, and normative factors that contribute to HIV risk.
The HIV Structural Reference Database will aid in developing strategies to inhibit HIV protease activity and understand mutations that make the virus resistant to certain drugs. The database contains annotated structural data from published literature and laboratory contributions.
A mobile testing van was introduced in Zimbabwe's Epworth and Seke areas, offering free rapid HIV tests with same-day results. The initiative reduced structural barriers by providing convenient access to testing and increased acceptance of rapid tests due to same-day results.
A recent study by researchers at the Gladstone Institute of Virology and Immunology investigated potential superinfection involving variations within HIV-1B. The findings, presented at the XV International AIDS Conference, suggest that superinfection may be restricted to a short window period after seroconversion.
Young men in rural Malawi associate HIV with masculinity and engage in risky behavior to demonstrate virility. This misunderstanding of AIDS risk has significant implications for future research and HIV prevention education.
FUZEON shows significant benefits in health improvements and reduced side effects for HIV patients, yet many are missing out due to fear of injection. Physicians and nurses play a pivotal role in educating patients on optimal use of FUZEON.
A study found that gender-and culturally-tailored HIV prevention programs reduced HIV incidence among African American teen girls. The interventions also showed promise in reducing chlamydia cases and promoting healthier relationships.
A study found that rapid HIV testing during labor can provide accurate results within 66 minutes, enabling women to receive antiretroviral prophylaxis. The study also showed higher test acceptance among younger women and those with limited prenatal care, highlighting the importance of early testing for pregnant women.
A randomized trial found that two short drug regimens for infants at birth reduced mother-to-child transmission of HIV compared to a single regimen. The study suggests several options for prevention, including voluntary counseling and testing, standard NVP prophylaxis, and postexposure prophylaxis.
A randomized, controlled clinical trial found that a targeted HIV prevention intervention significantly reduced consistent condom use and risky sexual behaviors in high-risk African-American adolescent girls. The intervention emphasized ethnic and gender pride, HIV knowledge, communication, and healthy relationships.
A randomized trial found that tenofovir disoproxil fumarate achieved high viral load suppression rates, comparable to stavudine-based regimens. Tenofovir DF was also associated with lower toxicity and better lipid profiles.
The Lancet discusses new design changes to the journal, including open-access policies and electronic document posting. The article also explores various HIV/AIDS strategies for developing countries, including expanded access to treatment and prevention efforts. Researchers emphasize the importance of local solutions and community-led ...
The UCSF Center for HIV Information has released the third edition of a CD-ROM targeting healthcare professionals in developing countries. The resource includes 5,000 pages of text on treatments, drugs, and standards of care from various countries.
The Emory Vaccine Center's Hope Clinic will conduct clinical trials for topical vaginal microbicide gels to prevent HIV transmission, particularly among women in Atlanta and worldwide. The trials aim to test the safety and acceptability of two different gel formulations on healthy and high-risk individuals.
Researchers found that APOBEC3F protein can evade VIF's destruction of retroviral restrictors, potentially contributing to HIV resistance. The 'search and destroy' defense of APOBEC proteins may play a crucial role in resisting HIV infection.
Nigerian naval personnel are putting themselves and their partners at risk by denying the existence of AIDS and engaging in risky sexual behaviors. A recent survey found that nearly half of sailors had sex with a female sex worker without using a condom, despite having good knowledge of AIDS-related information.
Researchers found that GBV-C infection slows HIV growth and increases survival in HIV patients. The harmless virus boosts immune proteins, which prevent HIV from infecting cells.
Researchers identified six Lactobacillus strains capable of binding to the HIV envelope, inhibiting infection and potentially blocking transmission. The bacteria also bound to immune cells, causing them to clump and immobilize any infected cells.
Researchers at the Salk Institute have made a breakthrough in understanding how HIV replicates within host cells. The study revealed that molecules exist in cells that help convert HIV's RNA genome to DNA, allowing for the production of new virus particles.
Research has identified improved screening programs for HIV coinfection with chronic hepatitis C, as well as predictive models for inflammation and fibrosis in patients with chronic hepatitis B. These advances aim to improve treatment decisions and quality of life for affected individuals.
A study found that urban American Indian women are at higher risk for contracting HIV due to elevated rates of trauma, including physical and sexual abuse. The research suggests that these women may be exposed to HIV infection despite reports of low risk, highlighting the need for assessments of trauma and prevention measures.
Researchers found that patients taking prednisolone had significantly higher CD4+ T-cell counts after two years compared to those not taking the drug. After five years, over 10% of patients on prednisolone maintained high CD4+ T-cell counts.
Between 1988 and 2000, New York State's HIV prevalence among childbearing women decreased steadily, with a 49% decrease in NYC and a 24% decline statewide. This decline was largely attributed to the widespread use of highly active antiretroviral therapy and targeted efforts aimed at minority populations.
Jay Levy's research has significantly impacted our understanding of HIV and the immune system, leading to major breakthroughs in antiviral responses. His work has also improved the safety of blood products for hemophiliacs and shed light on the role of plasmacytoid dendritic cells in HIV infection.
A South African study found that women experiencing gender-based violence are more likely to contract HIV due to abusive partners imposing risky sexual practices. The research highlights the need for effective interventions to address social constructions of masculinity and intimate partner violence in relation to HIV risk.
Researchers discover HIV mutations that prevent immune system from recognizing protein fragments, allowing virus to replicate and increase in number. This finding highlights the importance of considering nearby regions not recognized by the immune system when designing vaccines.
A study published in Circulation found that HIV infection is an independent predictor of carotid artery intima-media thickness (IMT), which increases the risk of heart attack and stroke. Aggressive treatment of high cholesterol, blood pressure, and other risk factors is crucial for HIV patients.
Researchers found HIV patients had significantly larger carotid IMT and higher rates of plaque build-up compared to uninfected controls. The study suggests HIV infection may be an independent risk factor for atherosclerosis, with lowest CD4 counts associated with thickest artery walls.
Researchers found that dual-infection with HIV and GBV-C leads to better outcomes, including slower progression to AIDS and lower mortality rates. Understanding the mechanism behind this phenomenon could lead to the development of improved therapies.
The study highlights the dangers of crystal methamphetamine use on HIV risk, particularly among young men who have sex with men. Methamphetamine can suppress a part of the immune system important in fighting off HIV, increasing the risk of infection and contracting the disease.
Researchers at Dana-Farber Cancer Institute have identified a protein, TRIM5-alpha, that blocks HIV replication in monkey cells. This discovery opens new avenues for intervening in early HIV infection and provides critical insights into viral uncoating, a little understood step in the viral lifecycle.
A new analysis of FUZEON data found that it does not increase lipodystrophy or glucose levels in pre-treated HIV patients. The treatment also showed a lower incidence of diarrhoea compared to other ARV regimens.